Please select the option that best describes you:

Do you utilize consolidative radiation for metastatic NSCLC lung cancer patients on maintenance immunotherapy?  

Or do you reserve in case of oligo-progression or progressive/symptomatic disease? 



Answer from: Medical Oncologist at Community Practice
Sign in or Register to read more